文献速递糖尿病肥胖与代谢综合征

肥胖合并2型糖尿病患者RYGB术后脂肪组织形态、基因表达与代谢的早期变化

Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

RYGB术后4周和24周除1例外均停用降糖药,空腹血糖、HbA1c和胰岛素水平下降,Matsuda指数升高(均P<0.01);脂肪细胞平均体积显著减小(4周比24周更明显),但脂肪细胞胰岛素敏感性未改变。结论:RYGB术后血糖控制和体内胰岛素敏感性在4周内改善,但脂肪细胞胰岛素敏感性未变,T2D快速改善机制可能主要发生在脂肪以外的组织。

要点

  • RYGB术后4周和24周,除1例外所有患者停用降糖药,空腹血糖、HbA1c和胰岛素下降,Matsuda指数升高(均P<0.01)。
  • 脂肪细胞平均体积显著减小,4周时减小程度大于24周;4周时每脂肪细胞葡萄糖摄取降低,异丙肾上腺素刺激的脂解有增加趋势。
  • 脂肪细胞对葡萄糖摄取和脂解的胰岛素效应倍数未变;脂肪酸氧化相关基因CPT1b和脂联素表达在4周时增加,瘦素和E2F1表达降低(均P<0.05)。

核心结论

  • RYGB术后4周血糖控制和体内胰岛素敏感性改善,但脂肪细胞胰岛素敏感性未改变,尽管脂肪细胞体积明显减小。
  • T2D术后快速改善的机制可能主要发生在脂肪以外的组织。

研究设计与样本

  • 评估包括口服葡萄糖耐量试验、皮下脂肪组织活检(基因表达、脂肪细胞大小、葡萄糖摄取、脂解和胰岛素作用)。

主要发现

  • RYGB术后4周和24周,除1例外所有患者停用糖尿病药物;空腹血糖、HbA1c和胰岛素水平较基线下降,Matsuda指数升高(均P<0.01)。
  • 脂肪细胞平均体积显著减小,4周时减小程度大于24周。
  • 4周时每脂肪细胞葡萄糖摄取降低,异丙肾上腺素刺激的脂解有增加趋势,而胰岛素对葡萄糖摄取和脂解的效应倍数未变。
  • 4周时脂肪酸氧化相关基因CPT1b和脂联素表达增加,瘦素和参与细胞增殖的E2F1表达降低(均P<0.05)。

临床怎么用

  • RYGB术后早期血糖改善可能不依赖于脂肪细胞胰岛素敏感性的恢复,临床评估代谢改善时需考虑脂肪外组织的作用。

局限性

  • 仅评估皮下脂肪组织,未涉及其他脂肪库或脂肪外组织机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Roux-en-Y gastric bypass (RYGB) surgery effectively prevents or treats type 2 diabetes (T2D). Adipose tissue (AT) mechanisms may be of importance. OBJECTIVE: To assess the relationship between early changes in whole-body and AT metabolism in surgically treated patients with T2D. DESIGN AND SETTING: A randomized single-center study. PATIENTS: Nineteen patients with T2D with body mass index 30 to 45 kg/m2. INTERVENTIONS: Thirteen patients were assessed at baseline and 4 and 24 weeks after RYGB (preceded by a 4-week low-calorie diet) and compared with 6 control patients continuing standard medical treatment: oral glucose tolerance test, subcutaneous AT biopsies for gene expression, adipocyte size, glucose uptake, lipolysis, and insulin action. RESULTS: At 4 and 24 weeks post-RYGB, all patients but one had stopped diabetes medication. Fasting glucose, HbA1c, and insulin levels decreased and the Matsuda index increased compared with baseline (P < 0.01 for all), indicating improved whole-body insulin sensitivity. Mean adipocyte size significantly reduced, more at 4 than at 24 weeks; at 4 weeks, glucose uptake per adipocyte was lowered, and isoproterenol-stimulated lipolysis tended to increase, whereas the fold insulin effects on glucose uptake and lipolysis were unchanged. Expression of genes involved in fatty acid oxidation, CPT1b and adiponectin, was increased at 4 weeks, whereas leptin and E2F1 (involved in cell proliferation) were reduced (P < 0.05 for all). CONCLUSION: Glycemic control and in vivo insulin sensitivity improved 4 weeks after RYGB, but adipocyte insulin sensitivity did not change despite a marked reduction in adipocyte size. Thus, mechanisms for a rapid improvement of T2D after RYGB may occur mainly in other tissues than adipose.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Katsogiannos P, Kamble PG, Boersma GJ, et al. Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D. J Clin Endocrinol Metab. 2019. PMID: 30689903. doi:10.1210/jc.2018-02165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。